Depuy合成，一部分约翰逊和约翰逊医疗设备集团已经推出了新的3D印刷钛脊柱植入线。这些设备被命名为Conder interbody平台，是第一个使用德国商标技术的版本新兴的植入技术(EIT) since it wasacquired by Johnson & Johnson Medical GmbH在2018年。
纳达夫·汤默（Nadav Tomer）, Worldwide President of Spine at DePuy Synthes, comments, “Our goal as a spine business is to focus on the areas with the most potential to solve unmet clinical needs, and we are excited to add advanced materials to our interbody portfolio as another option for surgeons,”
“导管投资组合的推出，以及我们针对退行性椎间盘疾病的全面植入物产品，有助于我们提供增强寿命的脊柱解决方案，从而促进各地患者的护理标准。”
EIT Cellular Titanium
导管是一种使用EIT细胞钛制成的新植入物，是一种具有与人骨骼核心的取消组织相当的弹性模量的材料。有多种形状和尺寸（部分取决于它们植入的方向），每个导管植入物都采用格子中心设计。与天然突破性骨的非典型50 - 90％的孔隙率相比，这种结构使植入物多孔80％。植入物的有组织的多孔结构会随着人体愈合而促进自然骨的嫁接。
导管implants are used to treat collapsed discs to occur in degenerative spine disease. Dr. Wilson Z. Ray, a Neurological Surgeon and consultant to DePuy Synthes Spine has had direct experience with the devices, for both the lumbar (lower back) and cervical (neck) regions of the spine. One of the advantages noted by Dr. Ray are the implants’ visibility during post-operation monitoring. “The implant allows for superior visualization,” he comments, “virtually no scatter on CT scan and early fusion assessment as compared to other titanium interbody devices.”
Depuy合成and additive manufacturing
Depuy合成is committed to supporting the development of additive manufacturing in medical. Following the acquisition of EIT, the company invested通过其爱尔兰创新中心3600万欧元在3D打印中推进材料科学。该公司还拥有3D打印技术from Michigan-based组织再生系统并有一个longstanding surgical guide production partnership with Materialise.
特别是对于3D打印的脊柱植入物，该公司与美国医疗设备制造商等公司竞争Stryker，目前声称有“the largest portfolio of 3D printed cages on the market。”
有关更多3D医疗更新订阅3D Printing Industry newsletter， 跟着我们推特and like us onFacebook. Seeking jobs in engineering? Make your profile on3D Printing Jobs, or广告to find experts in your area.
特色图像显示了DePuy合成的导管室内平台，其带有EIT蜂窝钛技术。通过Johnson＆Johnson医疗设备的照片
